Article Sidebar

Download
View Article
Statistic
Read Counter : 30 Download : 16

Main Article Content

Abstract

Adipose tissue produces adipokines, and adipocytes have an impact on the reproductive organs through the production of adiponectin and leptin. Therefore, it is essential to evaluate adipokines and sex hormones in order to have a deeper understanding of infertility. Thus, the goal of the current study was to assess adipokines and biochemical markers in infertile patients. In this study, 65 women between the ages of 17 and 40 years old (mean: 27.8±4.08 years) were included. All were consecutively admitted to the clinic at AL-Kut Hospital for Gynecology Obstetrics and Pediatrics (infertility center) at February to May 2024. All women had infertility as diagnosed by the physician. also, this study including 40 healthy women as control group. The results showed that the concentrations of follicle stimulating hormone (7.42±0.13) and luteinising hormone (LH) (7.13±0.25) in serum of infertility women indicated a significant (P <0.05) rise in contrast to healthy women (5.037.42±0.29; 3.657.42±0.16). The levels of MDA (1.93±0.11) demonstrated significant (P <0.05) increase and GSH (0.371±0.027) decreased in infertility women compared with healthy women (1.22±0.09; 0.441±0.014). Adiponectin concentration in serum of infertility patients (4.55±0.19) indicated non-significant (P <0.05) variations in contrast to healthy women (4.61 ± 0.23). the concentration of leptin indicated a significant (P <0.05) rise in infertility women (14.83 ±1.92) in contrast to healthy women (5.48 ±0.41). It is concluded from the study that there was also an imbalance in the case of oxidative stress. On the other hand, it was noted that there is a correlation between leptin levels and infertility in women

Keywords

Adipokines Infertility Leptin Adiponectin oxidative status

Article Details

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite
AlSadoon, A. K. (2024). REVEAL OF CERTAIN ADIPOKINES (ADIPONECTIN AND LEPTIN) AND PHYSIOLOGICAL PARAMETERS LEVELS IN WOMEN WITH INFERTILITY. Journal of Medical Genetics and Clinical Biology, 1(8), 253–261. https://doi.org/10.61796/jmgcb.v1i8.854
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. . W. Kuohung, M. D. Hornstein, R. L. Barbieri, and V. A. Barss, Evaluation of Female Infertility, version 17.3, 2009.
  2. . W. E. Olooto, A. A. Amballi, and T. A. Banjo, “A Review of Female Infertility: Important Etiological Factors and Management,” J. Microbiol. Biotech. Res., vol. 2, no. 3, pp. 379-385, 2012.
  3. . U. Larsen, “Research on Infertility: Which Definition Should We Use?,” Fertility and Sterility, vol. 83, no. 4, pp. 846-852, 2005.
  4. . C. Krausz, A. R. Escamilla, and C. Chianese, “Genetics of Male Infertility: From Research to Clinic,” Reproduction, vol. 150, no. 5, pp. R159-R174, 2015.
  5. . N. M. Ali, H. M. Ahmed, and S. Enaas, “Hepatitis C Virus and Infertility,” University of Thi-Qar Journal of Science, vol. 9, no. 2, pp. 7-12, 2022.
  6. . Z. Ö. Dönmez and B. D. Demirtaş, “Impact of Obesity on Infertility in Women,” J. Turk. Ger. Gynecol. Assoc., vol. 16, pp. 111-117, 2015.
  7. . E. S. Jungheim, J. L. Travieso, K. R. Carson, and K. H. Moley, “Obesity and Reproductive Functions,” Obstet. Gynecol. Clin. North Am., vol. 39, pp. 479-493, 2012.
  8. . N. S. Rasoul, J. Fadhil, and I. K. Yasameen, “Serum Adiponectin – Marker in Women with Polycystic Ovary Syndrome,” Kerbala Journal of Pharmaceutical Sciences, vol. 1, no. 23, pp. 22-30, 2024.
  9. . A. M. Al-Naddawi, S. M. Nawar, and A. H. Rana, “Determination of Serum Adiponectin Levels in Normal Weight Women with Polycystic Ovary Syndrome,” Journal of the Faculty of Medicine Baghdad, vol. 57, no. 2, pp. 175-178, 2015.
  10. . M. F. Palin, V. V. Bordignon, and B. D. Murphy, “Adiponectin and the Control of Female Reproductive Functions,” Vitam. Horm., vol. 90, pp. 239-287, 2012.
  11. . M. Herrid, S. K. Palanisamy, U. A. Ciller, R. Fan, P. Moens, N. A. Smart, and J. R. McFarlane, “An Updated View of Leptin on Implantation and Pregnancy: A Review,” Physiol. Res., vol. 63, pp. 543-557, 2014.
  12. . C. S. Mantzoros, F. Magkos, M. Brinkoetter, E. Sienkiewicz, T. A. Dardeno, S. Y. Kim, O. P. Hamnvik, and A. Koniaris, “Leptin in Human Physiology and Pathophysiology,” Am. J. Physiol. Endocrinol. Metab., vol. 301, no. 5, pp. E567-E584, 2011.
  13. . S. M. Khan, O. P. Hamnvik, M. Brinkoetter, and C. S. Mantzoros, “Leptin as a Modulator of Neuroendocrine Function in Humans,” Yonsei Med. J., vol. 53, no. 4, pp. 671-679, 2012.
  14. . A. A. Abdullah, M. Ahmed, and A. Oladokun, “Leptin Levels in Women with Unexplained Infertility: A Systematic Review and Meta-Analysis,” World J. Meta-Anal., vol. 10, no. 1, pp. 37-45, 2022.
  15. . M. R. Abdul, S. M. Rahim, and A. H. Saleh, “Cardioprotective Activity of Costus Root Ethanol Extract in Experimentally-Induced Hypothyroidism in Female Albino Rats,” HAYATI J. Biosci., vol. 30, no. 6, pp. 1054–1060, 2023.
  16. . H. Fakhoury, H. Tamim, M. Ferwana, I. A. Siddiqui, M. Adham, and W. Tamimi, “Age and BMI Adjusted Comparison of Reproductive Hormones in PCOS,” J. Family Med. Prim. Care, vol. 1, no. 2, pp. 132-136, 2012.
  17. . S. Esmaeilzadeh, M. G. Andarieh, R. Ghadimi, and M. A. Delavar, “Body Mass Index and Gonadotropin Hormones (LH and FSH) Associate with Clinical Symptoms among Women with Polycystic Ovary Syndrome,” Glob. J. Health Sci., vol. 7, no. 2, pp. 101-106, 2015.
  18. . V. Insler, Z. Shoham, and A. Barash, “Polycystic Ovaries in Non-Obese and Obese Patients: Possible Pathophysiological Mechanism Based on New Interpretation of Facts and Findings,” Hum. Reprod., vol. 8, no. 3, pp. 379-384, 1993.
  19. . Y. L. Yanira, S. S. Serene, J. Yarisie, E. Anne, G. Sabrina, and E. H. Janet, “Inverse Relationship between Luteinizing Hormone and Body Mass Index in Polycystic Ovarian Syndrome: Investigation of Hypothalamic and Pituitary Contributions,” J. Clin. Endocrinol. Metabol., vol. 91, no. 4, pp. 1309-1316, 2006.
  20. . A. H. Alnakash and N. K. Al-Tae’e, “Polycystic Ovarian Syndrome: The Correlation between the LH/FSH Ratio and Disease Manifestations,” Middle East Fertil. Soc. J., vol. 12, no. 1, pp. 35-40, 2007.
  21. . M. A. Fritz and L. Speroff, Clinical Gynecologic Endocrinology and Infertility, 8th ed., Philadelphia, PA: Lippincott Williams & Wilkins, 2011, pp. 501-518.
  22. . H. Ye, G. N. Huang, P. H. Zeng, and L. Pei, “IVF/ICSI Outcomes between Cycles with Luteal Estradiol (E2) Pre-Treatment before GnRH Antagonist Protocol and Standard Long GnRH Agonist Protocol: A Prospective and Randomized Study,” J. Assist. Reprod. Genet., vol. 26, no. 2-3, pp. 105-111, Mar. 2009.
  23. . M. Liu, S. Liu, L. Li, P. Wang, H. Li, and Y. Li, “LH Levels May Be Used as an Indicator for the Time of Antagonist Administration in GnRH Antagonist Protocols—A Proof-Of-Concept Study,” Front. Endocrinol., vol. 10, p. 67, 2019.
  24. . F. Lisi, L. Rinaldi, S. Fishel, D. Caserta, R. Lisi, and A. Campbell, “Evaluation of Two Doses of Recombinant Luteinizing Hormone Supplementation in an Unselected Group of Women Undergoing Follicular Stimulation for In Vitro Fertilization,” Fertil. Steril., vol. 83, pp. 309-315, 2005.
  25. . N. Jain, S. Malik, and V. Prakash, “Impact of Various PCOS Phenotypes on Oocyte Competence in an ART Cycle,” Clin. J. Obstet. Gynecol., vol. 5, pp. 67-71, 2022.
  26. . H. K. K. M. Rawdhah, A. T. N. AL Hasnawi, and Z. J. Hadi, “Role of Interleukin 17A Gene Polymorphism and Serum Level in Patients with Polycystic Ovary Syndrome,” Human Reproduction, vol. 15, no. 6, pp. 1221–1224, Jun. 2023.
  27. . B. Yildirim, S. Demir, I. Temur, R. Erdemir, and B. Kaleli, “Lipid Peroxidation in Follicular Fluid of Women with Polycystic Ovary Syndrome,” J. Reprod. Med., vol. 52, no. 8, pp. 722, 2007.
  28. . S. Mehendale, B. Kilari, C. Deshmukh, B. Dhorepatil, V. Nimbargi, and S. Joshi, “Oxidative Stress-Mediated Essential Polyunsaturated Fatty Acid Alterations in Female Infertility,” Department of Obstetrics and Gynecology, Bharati Vidyapeeth University Medical College, vol. 12, no. 1, pp. 28-30, 2009.
  29. . X. Liu, F. Wang, Y. Li, and C. Sun, “Oxidative Stress and the Susceptibility to Obesity in Rats,” Wei Sheng Yan Jiu, vol. 40, no. 4, pp. 420-422, 2011.
  30. . Y. Dinger, T. Akcay, T. Erdem, I. Saygili, and S. Gundogdu, “DNA Damage, DNA Susceptibility to Oxidation and Glutathione Level in Women with Polycystic Ovary Syndrome,” Scand. J. Lab. Investig., vol. 65, no. 8, pp. 721-728, 2005.
  31. . I. M. W. Ebisch, C. M. G. Thomas, W. H. M. Peters, D. D. M. Braat, and R. P. M. Steegers-Theunissen, “The Importance of Folate, Zinc, and Antioxidants in the Pathogenesis and Prevention of Subfertility,” Hum. Reprod. Update, vol. 13, no. 2, pp. 163–174, 2007.
  32. . S. Panwar, M. Herrid, K. G. Kauter, and J. R. McFarlane, “Effect of Passive Immunization Against Leptin on Ovarian Follicular Development in Prepubertal Mice,” J. Reprod. Immunol., vol. 96, pp. 19-24, 2012.
  33. . A. Pérez-Pérez, F. Sánchez-Jiménez, J. Maymó, J. L. Dueñas, C. Varone, and V. Sánchez-Margalet, “Role of Leptin in Female Reproduction,” Clin. Chem. Lab. Med., vol. 53, pp. 15-28, 2015.
  34. . B. Demir, G. Suleyman, S. Seda, and A. Yildiz, “Serum Leptin Level in Women with Unexplained Infertility,” J. Reprod. Immunol., vol. 75, no. 2, pp. 145-149, 2007.
  35. . P. F. Svendsen, M. Christiansen, P. L. Hedley, et al., “Adipose Expression of Adipocytokines in Women with Polycystic Ovary Syndrome,” Fertil. Steril., vol. 98, no. 1, pp. 235–241, Jul. 2012.